Cargando…

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma

This Letter to the Editor responds to recent comments by Jiang et al. and joins the recommendation for further investigations into the role of TP53alteration status and TMB as predictors of response to immunotherapy and survival in head and neck squamous cell carcinoma.

Detalles Bibliográficos
Autores principales:	Burcher, Kimberly M, Wilson, Harper L, Gavrila, Elena, Abreu, Arianne, D’Agostino, Ralph B, Zhang, Wei, Porosnicu, Mercedes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256026/ https://www.ncbi.nlm.nih.gov/pubmed/35552454 http://dx.doi.org/10.1093/oncolo/oyac088

Ejemplares similares

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
por: Burcher, Kimberly M., et al.
Publicado: (2021)

A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers
por: Burcher, Kimberly M., et al.
Publicado: (2022)

The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma
por: Wilson, Harper L., et al.
Publicado: (2020)

Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature
por: Bloomer, Chance H., et al.
Publicado: (2023)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

Prevalence of DNA Repair Gene Mutations in Blood and Tumor Tissue and Impact on Prognosis and Treatment in HNSCC
por: Burcher, Kimberly M., et al.
Publicado: (2021)

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy
por: Jiang, Chao, et al.
Publicado: (2022)

Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma
por: Matsuda, Shinichi, et al.
Publicado: (2020)

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma
por: Shi, Congyu, et al.
Publicado: (2021)

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010)

Ricolinostat enhances adavosertib-induced mitotic catastrophe in TP53-mutated head and neck squamous cell carcinoma cells
por: Miyake, Keitaro, et al.
Publicado: (2022)

Exosomal microRNAs Targeting TP53 Gene as Promising Prognostic Markers for Head and Neck Squamous Cell Carcinoma
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2022)

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study
por: Peltonen, Jenni K, et al.
Publicado: (2011)

TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients
por: Kampel, Liyona, et al.
Publicado: (2023)

Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer
por: Hughes, Ryan T, et al.
Publicado: (2023)

Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status
por: Porosnicu, Mercedes, et al.
Publicado: (2022)

TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
por: Klinakis, Apostolos, et al.
Publicado: (2020)

Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer
por: Caponio, Vito Carlo Alberto, et al.
Publicado: (2020)

Reply to “CRISPR screens are feasible in TP53 wild‐type cells”
por: Haapaniemi, Emma, et al.
Publicado: (2019)

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2023)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
por: Loeb, Keith R., et al.
Publicado: (2012)

Impact of Low-Burden TP53 Mutations in the Management of CLL
por: Lazarian, Gregory, et al.
Publicado: (2022)

Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta‐analysis on HPV, p16, and TP53
por: Mulder, Frans J., et al.
Publicado: (2020)

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss
por: Gross, Andrew M, et al.
Publicado: (2014)

Nucleotide variants and protein expression of TP53 in a Sri Lankan cohort of patients with head and neck cancer
por: Manoharan, Vahinipriya, et al.
Publicado: (2019)

Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer
por: Mitra, Sanga, et al.
Publicado: (2014)

In reply to: Impact of COVID-19 on head and neck mucosal squamous cell carcinoma: Correspondence
por: Stevens, Madelyn N., et al.
Publicado: (2022)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)
por: Alam, Md Maksudul, et al.
Publicado: (2023)

Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer
por: van Ginkel, Joost H., et al.
Publicado: (2016)

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
por: Mineta, H., et al.
Publicado: (1998)

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
por: Omura, Go, et al.
Publicado: (2017)

Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites
por: Guan, Xiaoxiang, et al.
Publicado: (2013)

Genome-Wide Analysis of Head and Neck Squamous Cell Carcinomas Reveals HPV, TP53, Smoking and Alcohol-Related Allele-Based Acquired Uniparental Disomy Genomic Alterations()
por: Tuna, Musaffe, et al.
Publicado: (2019)

Homozygous deletions of UGT2B17 modifies effects of smoking on TP53-mutations and relapse of head and neck carcinoma
por: Mafune, Aki, et al.
Publicado: (2015)

p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
por: Ganly, I, et al.
Publicado: (2000)

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
por: de Bakker, Tycho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6eguegn0cvklhlcss7qv62daq5